About This Event
Join global experts, regulators, and industry leaders for a two-day workshop focused on Chemistry, Manufacturing, and Controls (CMC) considerations for biotechnology and advanced therapy products (ATPs). Co-hosted by USP and NEU under the APEC Center of Excellence for Advanced Therapies, this event will explore the evolution from traditional biologics to cutting-edge gene and cell therapies from a CMC perspective. Attendees will gain insights into regulatory expectations, comparability approaches, platform strategies, and the challenges of global harmonization.
This workshop is ideal for regulatory professionals, CMC scientists, and developers of advanced therapy products seeking to stay ahead in this rapidly evolving field.
Highlights include:
- Sessions on platform strategies and comparability for CGT products
- Global regulatory perspectives and panel discussions
- Real-world case studies from industry leaders
- Networking opportunities with experts from the industry and regulatory bodies.
Date and Time
October 1-2 (2 day event)
Location
Marriott Dongdaemun, Seoul, Korea
Cost
- $1,000 Industry Fee
- $750 Government and Academia Fee
Register here
Register Now
Secure your spot today to join leading regulators and industry experts in Seoul for the workshop on CMC Considerations for Biotechnology and Advanced Therapy Products.
